Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

The impact of postrandomization crossover of therapy in acute coronary syndromes care.

Mahaffey KW, Pieper KS, Lokhnygina Y, Califf RM, Antman EM, Kleiman NS, Goodman SG, White HD, Rao SV, Hochman JS, Cohen M, Col JJ, Roe MT, Ferguson JJ; SYNERGY Investigators.

Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):211-9. doi: 10.1161/CIRCOUTCOMES.109.853598. Epub 2011 Feb 8.

PMID:
21304094
[PubMed - indexed for MEDLINE]
Free Article
2.

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S.

N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475. Erratum in: N Engl J Med. 2010 Oct 14;363(16):1585.

PMID:
20818903
[PubMed - indexed for MEDLINE]
Free Article
3.

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Di Pasquale G, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KA, Yusuf S; CURRENT-OASIS 7 trial investigators.

Lancet. 2010 Oct 9;376(9748):1233-43. doi: 10.1016/S0140-6736(10)61088-4.

PMID:
20817281
[PubMed - indexed for MEDLINE]
4.

Cardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry).

French JK, Harkness S, Sleeper L, Wong SC, Col J, Dzavik V, White HD, Hochman JS.

Am J Cardiol. 2009 Jul 1;104(1):24-8. doi: 10.1016/j.amjcard.2009.03.002. Epub 2009 May 4.

PMID:
19576316
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Early versus delayed invasive intervention in acute coronary syndromes.

Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S; TIMACS Investigators.

N Engl J Med. 2009 May 21;360(21):2165-75. doi: 10.1056/NEJMoa0807986.

PMID:
19458363
[PubMed - indexed for MEDLINE]
Free Article
6.

Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.

Spinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ 3rd, Rao SV, Gallo R, Ducas J, Goodman SG, Antman E, White HD, Biasucci L, Becker RC, Col JJ, Cohen M, Harrington RA, Califf RM; SYNERGY Trial Investigators.

Int J Cardiol. 2010 Sep 24;144(1):36-41. doi: 10.1016/j.ijcard.2009.03.119. Epub 2009 May 5.

PMID:
19406493
[PubMed - indexed for MEDLINE]
7.

Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP).

Rashba EJ, Lamas GA, Couderc JP, Hollist SM, Dzavik V, Ruzyllo W, Fridrich V, Buller CE, Forman SA, Kufera JA, Carvalho AC, Hochman JS; OAT-EP Investigators.

Circulation. 2009 Feb 17;119(6):779-87. doi: 10.1161/CIRCULATIONAHA.108.808626. Epub 2009 Feb 2.

PMID:
19188505
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.

Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Fox KA, Granger CB, Jolly S, Rupprecht HJ, Widimsky P, Yusuf S; CURRENT-OASIS 7 Steering Committee.

Am Heart J. 2008 Dec;156(6):1080-1088.e1. doi: 10.1016/j.ahj.2008.07.026. Epub 2008 Nov 1.

PMID:
19033002
[PubMed - indexed for MEDLINE]
9.

Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.

Mahaffey KW, Tonev ST, Spinler SA, Levine GN, Gallo R, Ducas J, Goodman SG, Antman EM, Becker RC, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM; SYNERGY Trial Investigators.

Int J Cardiol. 2010 Mar 4;139(2):123-33. doi: 10.1016/j.ijcard.2008.10.008. Epub 2008 Nov 14.

PMID:
19012977
[PubMed - indexed for MEDLINE]
10.

Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.

Gibson CM, Pride YB, Aylward PE, Col JJ, Goodman SG, Gulba D, Bergovec M, Kunadian V, Zorkun C, Buros JL, Murphy SA, Antman EM.

J Thromb Thrombolysis. 2009 Jan;27(1):11-7. doi: 10.1007/s11239-008-0264-4. Epub 2008 Aug 10.

PMID:
18695943
[PubMed - indexed for MEDLINE]
11.

Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.

Lopes RD, Alexander KP, Marcucci G, White HD, Spinler S, Col J, Aylward PE, Califf RM, Mahaffey KW.

Eur Heart J. 2008 Aug;29(15):1827-33. doi: 10.1093/eurheartj/ehn236. Epub 2008 Jun 2.

PMID:
18519426
[PubMed - indexed for MEDLINE]
Free Article
12.

[Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].

Marret S, Marpeau L, Follet-Bouhamed C, Cambonie G, Astruc D, Delaporte B, Bruel H, Guillois B, Pinquier D, Zupan-Simunek V, BĂ©nichou J; le groupe PREMAG.

Gynecol Obstet Fertil. 2008 Mar;36(3):278-88. doi: 10.1016/j.gyobfe.2008.01.012. Epub 2008 Mar 11. French.

PMID:
18337147
[PubMed - indexed for MEDLINE]
13.

Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.

Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RM; SYNERGY Trial Investigators.

J Gen Intern Med. 2008 Mar;23(3):310-6. doi: 10.1007/s11606-007-0498-4. Epub 2008 Jan 15.

PMID:
18196350
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Adenylyl cyclase-dependent axonal targeting in the olfactory system.

Col JA, Matsuo T, Storm DR, Rodriguez I.

Development. 2007 Jul;134(13):2481-9. Epub 2007 May 30.

PMID:
17537788
[PubMed - indexed for MEDLINE]
Free Article
15.

Prior health care experiences of adolescents who enroll in SCHIP.

Klein JD, Shenkman E, Brach C, Shone LP, Col J, Schaffer VA, Dick AW, VanLandeghem K, Szilagyi PG.

J Health Care Poor Underserved. 2006 Nov;17(4):789-807.

PMID:
17242531
[PubMed - indexed for MEDLINE]
16.

A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.

Cohen M, Mahaffey KW, Pieper K, Pollack CV Jr, Antman EM, Hoekstra J, Goodman SG, Langer A, Col JJ, White HD, Califf RM, Ferguson JJ; SYNERGY Trial Investigators.

J Am Coll Cardiol. 2006 Oct 3;48(7):1346-54. Epub 2006 Sep 12.

PMID:
17010793
[PubMed - indexed for MEDLINE]
Free Article
17.

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.

Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD; SHOCK Investigators.

JAMA. 2006 Jun 7;295(21):2511-5.

PMID:
16757723
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Fetal serum beta2-microglobulin as a marker for fetal infectious diseases.

Dreux S, Rousseau T, Gerber S, Col JY, Dommergues M, Muller F.

Prenat Diagn. 2006 May;26(5):471-4.

PMID:
16652403
[PubMed - indexed for MEDLINE]
19.

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.

Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, Berdan LG, Reist CJ, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ 3rd, Califf RM; SYNERGY Trial Investigators.

JAMA. 2005 Nov 23;294(20):2594-600.

PMID:
16304073
[PubMed - indexed for MEDLINE]
20.

Fetal anal incontinence evaluated by amniotic fluid digestive enzyme assay in myelomeningocele spina bifida.

Talabani H, Dreux S, Luton D, Simon-Bouy B, Le Fiblec B, Col JY, Guibourdenche J, Oury JF, Muller F.

Pediatr Res. 2005 Oct;58(4):766-70.

PMID:
16189207
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk